Cumberland Pharmaceuticals Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $45.4M | $34.5M | $38.2M | $39.9M | $40.9M | $54.3M | $70.6M | $65.9M |
| Accounts Receivable | $8.4M | $7.3M | $6.1M | $5.5M | $4.5M | $6.0M | $7.1M | $5.1M |
| Inventory | $6.7M | $5.4M | $4.3M | $5.6M | $5.7M | $6.2M | $5.8M | $7.7M |
| Total Current Assets | $68.7M | $65.5M | $64.6M | $70.8M | $68.7M | $87.2M | $87.3M | $81.0M |
| Property, Plant & Equipment | $528.9K | $464.5K | $536.5K | $651.0K | $880.6K | $1.2M | $1.1M | $1.2M |
| Goodwill | $0 | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $21.4M | $22.2M | $21.2M | $21.6M | $15.5M | $9.5M | $7.0M | $7.4M |
| Total Assets | $93.2M | $93.4M | $91.9M | $95.4M | $87.6M | $98.6M | $95.5M | $92.1M |
| Liabilities | ||||||||
| Accounts Payable | $9.0M | $8.0M | $2.9M | $3.2M | $2.0M | $2.8M | $1.5M | $2.1M |
| Total Current Liabilities | $17.7M | $14.8M | $12.4M | $13.7M | $7.5M | $8.1M | $6.6M | $9.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $29.3M | $20.3M | $15.1M | $14.7M | $8.3M | $13.0M | $12.7M | $14.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $11.7M | $18.6M | $19.5M | $18.8M | $16.4M | $18.5M | $12.7M | $7.0M |
| Total Stockholders' Equity | $64.1M | $73.2M | $76.9M | $80.8M | $79.5M | $85.7M | $82.9M | $77.8M |